首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   712篇
  免费   42篇
  国内免费   7篇
耳鼻咽喉   9篇
儿科学   11篇
妇产科学   11篇
基础医学   83篇
口腔科学   14篇
临床医学   89篇
内科学   107篇
皮肤病学   4篇
神经病学   47篇
特种医学   18篇
外科学   38篇
综合类   60篇
预防医学   170篇
眼科学   5篇
药学   68篇
中国医学   12篇
肿瘤学   15篇
  2024年   3篇
  2023年   12篇
  2022年   31篇
  2021年   35篇
  2020年   33篇
  2019年   30篇
  2018年   42篇
  2017年   25篇
  2016年   34篇
  2015年   34篇
  2014年   46篇
  2013年   64篇
  2012年   41篇
  2011年   49篇
  2010年   38篇
  2009年   30篇
  2008年   35篇
  2007年   28篇
  2006年   23篇
  2005年   21篇
  2004年   17篇
  2003年   15篇
  2002年   8篇
  2001年   6篇
  2000年   6篇
  1999年   6篇
  1997年   6篇
  1996年   2篇
  1995年   4篇
  1994年   1篇
  1993年   3篇
  1991年   2篇
  1990年   3篇
  1989年   2篇
  1988年   1篇
  1987年   1篇
  1986年   2篇
  1985年   2篇
  1984年   2篇
  1983年   4篇
  1981年   3篇
  1980年   4篇
  1979年   3篇
  1975年   2篇
  1974年   1篇
  1972年   1篇
排序方式: 共有761条查询结果,搜索用时 0 毫秒
1.
Prev-DAF试剂盒分析线粒体基因1555A-G突变   总被引:10,自引:14,他引:10  
目的建立应用标准试剂盒方法检测线粒体基因1555A-G(mtDNA1555A-G)突变的程序,进行母系遗传耳聋家系的基因型分析.方法采用Prev-DAF试剂盒分析14个母系遗传耳聋家系,共检测耳聋患者34个,正常个体11个,并以Alw26酶切和测序方法验证试剂盒检测的准确性.结果Prey-DAF试剂盒检测结果证实13个家系中33个耳聋患者携带有mtDNA1555A-G突变,另1个耳聋家系中的一名耳聋患者不携带此突变,11个正常个体中无此突变,试剂盒检测方法与Alw26I酶切法和测序结果完全吻合.结论在中国,mtDNA1555A-G氨基糖甙类抗生素致聋的家系多,分布广,Prev-DAF试剂盒在分析线粒体基因1555A-G突变方面具有简单、低耗、结果直观的特点,适合在中国用于进行此突变的大规模筛查或预防性检查.  相似文献   
2.
BackgroundClinicians often use physical performance tests (PPT) to measure performance measures in sports since they are easy to administer, portable, and cost-efficient. However, PPT often lack good or known psychometric properties. Perhaps, the 30-second chair-stand test (30CST) would be a good functional test in athletic populations as it has been shown to demonstrate good psychometric properties in older adults.Hypothesis/PurposeThe purpose of this study was to determine normative values for and concurrent, convergent and discriminative validity of 30CST for healthy young adults aged 19-35 years.Study DesignCross-sectionalMethodsEighty-one participants completed this study. All participants performed two trials of 30CST, 5-times sit-to-stand (5xSTS), and lateral step-up test (LSUT). Investigators used the International Physical Activity Questionnaire Leisure Domain (LD-IPAQ) to divide participants into insufficiently or sufficiently active groups based on the weekly metabolic equivalent of task per the Physical Activity Guidelines for Americans.ResultsParticipants (Mean + SD age, 25.1 ± 3.4 years; body height, 1.71 ± 0.09 m; body mass, 72.6 ± 16.1 kg; females 47) performed an average of 33.0±5.4 30CST repetitions. The 30CST performance was negatively associated with 5xSTS (r=-0.79 p=0.01) and positively associated with LSUT performances (r=0.51, p=0.01) when using Pearson correlations. In addition, the sufficiently active group performed significantly greater 30CST repetitions than the insufficiently active group (mean difference = 2.5; p=0.04).ConclusionsIn addition to finding a reference value for 30CST performance in young adults, investigators found that the 30CST displayed concurrent and convergent validity in assessing functional lower extremity (LE) muscle strength and discriminated between those with sufficient and insufficient physical activity levels. Training and rehabilitation professionals could use the 30CST for testing functional LE muscle strength for athletes in pre-season or during rehabilitation. Future investigators should perform studies to determine if 30CST predicts sport performance.Level of EvidenceLevel 2  相似文献   
3.
The application of ancillary studies, such as immunostains, to cytopathology has improved the ability to make accurate diagnoses with precise subclassification. Even with these techniques, there are still aspiration and exfoliative cytology cases for which it remains difficult to definitively determine the source and/or subtype. This article focuses on the well-established and novel ancillary studies used in the modern era of cancer diagnoses in cytopathology, particularly in the diagnostic work-up of metastatic tumors without a known primary.  相似文献   
4.

Background Context

Despite the prevalence and importance of myelopathy, there is a paucity of objective and quantitative clinical measures. The most commonly used diagnostic tools available are nonquantitative physical exam findings (eg, pathologic reflexes, and gait disturbance) and subjective scoring systems (eg, modified Japanese Orthopaedic Association [mJOA]). A decline in fine motor coordination is a hallmark of early myelopathy, which may be useful for quantitative testing.

Purpose

To identify if a novel tablet application could provide a quantitative measure of upper extremity dysfunction in cervical spondylotic myelopathy.

Study Design/Setting

Prospective cohort study Patient Sample: Adult patients with a diagnosis of cervical spondylotic myelopathy from a board-certified, spine surgeon were compared with age-matched, healthy, and adult control patients. Outcome Measures: Self-reported function was assessed via the mJOA. Upper extremity function was measured via the fine motor skills (FiMS) tablet test.

Methods

Subjects and controls prospectively completed the mJOA paper survey and the FiMS tablet testing, which consisted of four challenges.

Results

After age-matching, 65 controls and 28 myelopathic patients were available for comparison. The mean mJOA was 13.5 ± 2.9 in the myelopathic cohort and 17.3 ± 1.1 in the control cohort (p < .0001). The average scores for challenges 1–4 in control patients were 24.4, 16.3, 3.2, and 6.6, respectively, whereas the average scores for the myelopathic patients were 16.6, 10.5, 1.4, and 1.8, respectively (p values for all four challenges <.001). Based upon the 15 control subjects who repeated FiMS testing four sequential times, intrarater reliability was excellent, yielding an interclass correlation coefficient of 0.88

Conclusions

The FiMS tablet application produced significantly lower scores in a myelopathic cohort when compared with an age-matched control cohort. This is true for all four challenges in the FiMS tablet application. The test can be completed in 1.5 minutes, producing a reliable, quantitative measure of cervical myelopathy upper extremity function. In summary, the FiMS tablet application is a novel, easily administered, objectively quantifiable test for analyzing cervical spondylotic myelopathy.  相似文献   
5.
目的:探讨甲状旁腺鉴定(PGI)系统在甲状腺手术中快速鉴定甲状旁腺的临床价值。方法:收集2016年3月—2018年5月于江苏省原子医学研究所附属江原医院进行甲状腺手术的251例患者临床资料,所有患者术中用细针对可疑甲状旁腺组织进行穿刺,使用PGI系统通过检测穿刺组织液的甲状旁腺激素(PTH)浓度来鉴别是否为甲状旁腺,同时将穿刺的组织切少许送冷冻病理检查,以冷冻病理检测结果为对照标准,统计分析该鉴定系统鉴别甲状旁腺的准确性。结果:PGI系统共检测434份组织,其中无效检测16份,有效检测418份。在有效检测的组织中,PGI系统鉴定为甲状旁腺组织311份,非甲状旁腺组织组织107份;冷冻病理检查诊断为甲状旁腺组织314份,非甲状旁腺组织104份。两种检测方法有明显的一致性(к=0.969,P0.001)。使用PGI系统识别甲状旁腺的敏感度99.0%(309/312),特异度98.1%(104/106),阳性预测值99.4%(309/311),阴性预测值97.2%(104/107),误诊率1.9%(2/104),漏诊率1.0%(3/312),准确率98.8%(413/418)。所有患者术后均无出血或感染,均未出现永久性的甲状旁腺功能减退及喉返神经麻痹。结论:PGI系统可用于甲状腺手术中鉴别甲状旁腺组织,具有速度快、准确率高、操作简便、组织损伤小等特点。  相似文献   
6.
基因测序是实现肿瘤精准医疗的基础手段,可辅助肿瘤诊断、判断患者预后、指导靶向药物治疗等。近年来,基因测序技术已广泛应用于甲状腺癌的临床诊治工作中。但截至目前,不同医疗中心对基因测序适应证的把控、报告解读水平,以及各测序平台的检测结果可靠性参差不齐。本文通过分析基因检测在甲状腺癌诊治中应用的现状与问题,结合笔者个人临床经验,探讨基因检测在甲状腺癌诊治全程管理中的特殊性及其价值。  相似文献   
7.
Summary Indicator cells — tanned, surface stabilized sheep erythrocytes — were incubated for 1 h in supernatants of 3 h MLCs. Their electrophoretic mobility was measured by an analytical, carrier free electrophoresis system. The change in their mobility compared with an appropriate control was calculated in per cent and correlated with the conventional measured MLR-cpm. The correlation of the two quantities is statistically highly significant (p<0.01). Furthermore, the difference of the electrophoretic mobility values of the group of HLA-D-identical and the groups of HLA-D-haploidentical or -different donors is significant beyond the 1 level (p<0.0005). Our method enables, therefore recognition of a positive or negative MLC after only 4 h. Typing for HLA-D-determinants seems to be possible. This could be of great importance for histocompatibility testing and organ transplantation.  相似文献   
8.
Most neuropsychological assessments include at least one measure that is administered, scored, or interpreted by computers or other technologies. Despite supportive findings for these technology-based assessments, there is resistance in the field of neuropsychology to adopt additional measures that incorporate technology components. This literature review addresses the research findings of technology-based neuropsychological assessments, including computer- and virtual reality-based measures of cognitive and functional abilities. We evaluate the strengths and limitations of each approach, and examine the utility of technology-based assessments to obtain supplemental cognitive and behavioral information that may be otherwise undetected by traditional paper-and-pencil measures. We argue that the potential of technology use in neuropsychological assessment has not yet been realized, and continued adoption of new technologies could result in more comprehensive assessment of cognitive dysfunction and in turn, better informed diagnosis and treatments. Recommendations for future research are also provided.  相似文献   
9.
10.
Abstract

Background: Accurate, reliable assessment of upper extremity muscular power in persons with paraplegia caused by spinal cord injury (SCI) would provide an objective indication of their ability to generate the forces necessary for the performance of daily activities. Wingate Anaerobic Testing (WAnT) consists of a 30-second sprint test on a cycle ergometer and has been used widely in both athletic and research settings.

Purpose: To examine test-retest reliability of arm WAnT performance in persons with complete SCI and paraplegia.

Methods: Forty-three participants with thoracic-level paraplegia (T2 through T12) performed 2 trials of arm WAnT with 2 to 7 days between each trial. Testing was performed using a Monarch 834E ergometer with participants seated in their wheelchairs. Participants were directed to crank at maximal pace for 30 seconds against a resistance load equivalent to 3.5% of their body mass. The SMI OptoSensor 2000 system was used to determine values of peak power (Ppeak), mean power (Pmean), minimum power, and rate of fatigue, which were compared between trials using 1-way analysis of variance for repeated measures. Coeffi cients of determination (r2) were calculated between trials for Ppeak and Pmean.

Results: No significant diffe rence was found between trials for any of the power output variables. Regression analysis ind icat ed that Ppeak and Pmean were closely associated between the 2 trials (r2= 0.92 and 0.94, respectively).

Conclusion: Arm WAnT is a reliable measurement tool for the assessment of upper extremity muscular power in persons with complete paraplegia.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号